Showing results (681-690 of 2,563) with videos related to
Sort By:
Pageof 257
Drug Testing and Analysis|March 28, 2020
Low doses of recombinant human erythropoietin does not affect C-terminal FGF23 in healthy menJacob Bejder, Paul Robach, Anne-Kristine Lundby, et al.Drug Testing and Analysis|January 31, 2020
A machine learning approach for handling big data produced by high resolution mass spectrometry after data independent acquisition of small molecules - Proof of concept study using an artificial neural network for sample classificationGabriel L Streun, Marco P Elmiger, Akos Dobay, et al.Drug Testing and Analysis|March 15, 2020
Determination of ethyl glucuronide in human hair samples: Decontamination vs extractionAlexander Müller, Stefanie Iwersen-BergmannDrug Testing and Analysis|June 28, 2016
Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controlsJosef Dib, Cynthia Mongongu, Corinne Buisson, et al.Drug Testing and Analysis|October 27, 2019
Investigation of the metabolism of the selective androgen receptor modulator LGD-4033 in equine urine, plasma and hair following oral administrationCharlotte Cutler, Marjaana Viljanto, Pamela Hincks, et al.Drug Testing and Analysis|October 29, 2020
Horseradish-peroxidase-conjugated anti-erythropoietin antibodies for direct recombinant human erythropoietin detection: Proof of conceptSven C Voss, Nelson N Orie, Wesal El-Saftawy, et al.Drug Testing and Analysis|October 29, 2020
Fully automated dried blood spot sample handling and extraction for serological testing of SARS-CoV-2 antibodiesStefan Gaugler, Pierre-Edouard Sottas, Katharina Blum, et al.Drug Testing and Analysis|October 29, 2020
Linking long noncoding RNAs (lncRNAs) and doping detectionBernardo Bonilauri, Bruno DallagiovannaDrug Testing and Analysis|October 29, 2020
Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensisKlára Gotvaldová, Kateřina Hájková, Jan Borovička, et al.Drug Testing and Analysis|October 10, 2020
Cumyl-CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chainSebastian Halter, Benedikt Pulver, Maurice Wilde, et al.Pageof 257